Skip to main content
. Author manuscript; available in PMC: 2023 Aug 1.
Published in final edited form as: Neuropathol Appl Neurobiol. 2022 Jun 2;48(5):e12819. doi: 10.1111/nan.12819

TABLE 1.

Demographic, clinical and neuropathological characteristics of the 37 cases included in the study

Clinical diagnosis Case Brain region Sex Age of death (years) PMI Brain weight (grams) CDR NIA-AA ABC scores

Alzheimers disease 1 MFG/ITG F 64 7.3 870 3 A3, B3, C3
2 MFG/ITG M 59 9 1,090 3 A3, B3, C3
3 MFG F 67 9.7 1,001 2 A3, B3, C3
4 MFG/ITG M 64 6.8 1,197 3 A3, B3, C3
5 MFG M 71 6.5 1,029 3 A3, B3, C3
6 MFG/ITG F 74 9.8 1,215 3 A3, B3, C3
7 ITG F 75 6.9 1,006 3 A3, B3, C3
8 MFG M 60 6.1 912 3 A3, B3, C3
Argyrophilic grain disease 1 MFG/ITG F 88 17.8 1,280 0.5 A1, B2, C1
2 MFG/ITG M 77 4.9 1,236 0.5 A1, B1, C1
3 MFG/ITG M 87 6.4 1,225 0 A1, B1, C0
4 ITG M 68 8.3 1,511 1 A0, B2, C0
Corticobasal degeneration 1 MFG/ITG M 66 12.1 NA 0.5 A1, B1, C0
2 MFG/ITG F 64 8.6 1,187 0.5 A1, B1, C0
3 MFG/ITG M 73 8.2 1,192 3 A1, B1, C0
4 ITG M 79 5.7 1,414 0.5 A0, B1, C0
5 MFG F 64 7.8 1,132 0.5 A0, B1, C0
6 MFG/ITG F 64 6.1 1,157 3 A0, B1, C0
7 ITG F 63 5.8 1,023 1 A1, B1, C0
8 MFG M 63 11.9 1,152 3 A1, B1, C0
9 MFG M 78 24 NA 3 A1, B1, C0
10 MFG M 65 4.5 1,100 3 A1, B1, C0
Picks disease 1 MFG/ITG M 64 13.7 1,017 2 A1, B0, C0
2 MFG/ITG F 69 6.3 1,032 3 A0, B1, C0
3 MFG/ITG M 57 12.4 1,113 3 A1, B1, C0
4 ITG M 60 15.2 927 3 A0, B0, C0
5 MFG F 76 5.9 929 3 A1, B0, C1
6 ITG M 56 9.2 990 3 A1, B1, C1
Progressive supranuclear palsy 1 MFG F 69 18.5 1,132 0.5 A1, B1, C0
2 MFG/ITG M 70 13.4 1,134 0.5 A0, B1, C0
3 ITG M 68 10.1 1,250 0.5 A0, B0, C0
4 MFG/ITG F 86 5.3 1,011 1 A0, B1, C0
5 MFG/ITG F 68 13 1,170 0.5 A1, B0, C0
6 MFG/ITG M 80 7.9 1,285 2 A1, B1, C0
7 MFG/ITG F 73 7.1 1,183 0.5 A2, B1, C1
Control 1 MFG/ITG M 76 8.2 1,324 0 A1, B1, C1
2 MFG/ITG F 86 6.4 1,300 0 A0, B1, C0

Abbreviations: NIA-AA, National Institute on Aging and Alzheimers Association; MFG, Middle Frontal Gyrus; ITG, Inferior Temporal Gyrus.